<DOC>
	<DOC>NCT01392755</DOC>
	<brief_summary>This randomized, open-label study will evaluate the effect of food, and the effect of omeprazole and ranitidine on danoprevir co-administered with ritonavir. Volunteers will be assigned to one of two treatment groups. Volunteers in both groups will receive oral doses of danoprevir and ritonavir. In addition, volunteers in group 2 will receive oral doses of omeprazole and ranitidine. The anticipated time of the study is approximately 6 weeks.</brief_summary>
	<brief_title>A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<criteria>Adult healthy volunteers, aged 18 to 45 years, inclusive Weight &gt;/= 50.0 kg Body Mass Index (BMI) 18.0 to 32.0 kg/m2, inclusive Presence of any active or chronic disease Abnormal blood pressure Abnormal resting heart rate Abnormal ECG values History of any clinically significant cardiovascular or cerebrovascular disease Current smokers or subjects that have discontinued smoking &lt; 6 months prior to first dose of study drug Positive for hepatitis B, hepatitis C or HIV Positive test for drugs of abuse or alcohol Positive result for H. pylori Regular use of antacids, H2 blockers, proton pump inhibitors, or any investigational drug within 30 days of first dose of study medication History of clinically significant gastrointestinal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>